Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 354961 - 354980 out of 498428 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Poland | (M05BX07) vosoritide | Voxzogo, proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań, 1,2 mg | 10 fiol. proszku + 10 amp.-strzyk. 0,6 ml rozp. + 10 igieł + 10 strzyk. | Wholesale price with vat |
$0-0 |
$0-0 |
Achondroplasia | n/a |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 2 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 2 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 3 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 3 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 4 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 4 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 5 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 5 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 6 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 6 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 7 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 7 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 1 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 1 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 2 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 2 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 3 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 3 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 4 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 4 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 5 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 5 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 6 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 5 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 2 fiol. 5,5 ml + 7 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 7 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (M09AX09) onasemnogene abeparvovec | Zolgensma, roztwór do infuzji, 2 x 10¹³ vg/ml | 1 fiol. 5,5 ml + 8 fiol. 8,3 ml, 2 x 10¹³ vg/ml , 8 fiol. 8,3 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Poland | (N02AA01) morphine (adm: O) | MST Continus, tabl. powl. o zmodyfikowanym uwalnianiu, 10 mg | 60 szt., 10 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | MundipharmaA/S |
Poland | (N02AA01) morphine (adm: O) | MST Continus, tabl. powl. o zmodyfikowanym uwalnianiu, 100 mg | 60 szt., 100 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | MundipharmaA/S |
Poland | (N02AA01) morphine (adm: O) | MST Continus, tabl. powl. o zmodyfikowanym uwalnianiu, 200 mg | 60 szt., 200 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | MundipharmaA/S |
Poland | (N02AA01) morphine (adm: O) | MST Continus, tabl. powl. o zmodyfikowanym uwalnianiu, 30 mg | 60 szt., 30 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | MundipharmaA/S |
Poland | (N02AA01) morphine (adm: O) | MST Continus, tabl. powl. o zmodyfikowanym uwalnianiu, 60 mg | 60 szt., 60 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | MundipharmaA/S |